Botaretigene sparoparvovec

DB16814InvestigationalGene Therapies

Botaretigene sparoparvovec: Overview.

Also known as
AAV5-hRKp.RPGR · AAV5-RPGR · DNA (RECOMBINANT PSEUDOTYPED ADENO-ASSOCIATED VIRUS 5 VECTOR AAV-RPGR HUMAN RHODOPSIN KINASE PROMOTER FRAGMENT-REGULATED HUMAN RETINITIS PIGMENTOSA GTPASE REGULATOR RPGR-ORF15 ISOFORM GENE VARIANT PLUS ADENO-ASSOCIATED VIRUS 2 INVERTED TERMINAL REPEAT FL
Code names
AAV-RPGR

Resolves to

What you can answer from here — as of November 21, 2025

6Clinical trialsPhase, status and sponsor resolved per trial
Sign in

Which companies are running trials of Botaretigene sparoparvovec, in which indications and phases, and which of those programs are still active?

Create a free account or log in to explore the full data card.

Create Account